长链非编码RNA(LINC00565和LINC00641)作为多形性胶质母细胞瘤(GBM)分子标志物的预后价值
研究纳入35例新诊断GBM患者和15名健康对照,用实时PCR检测血样中lncRNA565和lncRNA641表达,用ROC曲线评估诊断效能,用Kaplan-Meier曲线分析无进展生存期和总生存期。结果显示两种lncRNA在GBM中表达显著升高,与更差体能状态相关,lncRNA565在大肿瘤(≥5 cm)中表达增加,两者高表达均与更差PFS和OS相关。作者认为液体活检样本中这两种lncRNA可作为GBM预后生物标志物。
要点
- GBM患者血中lncRNA565和lncRNA641表达较健康对照显著升高。
- 两种lncRNA高表达均与更差体能状态及更差PFS、OS相关。
- lncRNA565表达随肿瘤大小≥5 cm而增加。
核心结论
- 液体活检样本中lncRNA565和lncRNA641表达可作为GBM患者的预后生物标志物。
研究设计与样本
- 研究纳入35例新诊断GBM病例和15名健康个体,采集血样,用实时PCR评估lncRNA565和lncRNA641表达,用受试者工作特征曲线检测诊断效能,用Kaplan-Meier曲线研究无进展生存期和总生存期。
主要发现
- lncRNA565和lncRNA641在GBM组中的表达较对照组显著升高。
- 两种lncRNA的表达与研究GBM患者的临床病理数据和生存模式相关。
- 两种lncRNA水平较高均与更差体能状态相关。
- lncRNA565表达随大肿瘤尺寸(≥5 cm)而增加。
- 生存分析显示两种lncRNA升高均与更差PFS和OS相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIM: Glioblastoma multiforme (GBM) is primary brain tumor grade IV characterized by fast cell proliferation, high mortality and morbidity and most lethal gliomas. Molecular approaches underlying its pathogenesis and progression with diagnostic and prognostic value have been an area of interest. Long-non coding RNAs (lncRNAs) aberrantly expressed in GBM have been recently studied. The aim is to investigate the clinical role of lncRNA565 and lncRNA641 in GBM patients. PATIENTS AND METHODS: Blood samples were withdrawn from 35 newly diagnosed GBM cases with 15 healthy individuals, then lncRNA565 and lncRNA641 expression were evaluated using real time-PCR. Their diagnostic efficacy was detected using receiver operating characteristic curve. Progression free survival (PFS) and overall survival (OS) were studied using Kaplan-Meier curves. RESULTS: lncRNAs expressions were increased significantly among GBM as compared to control group. Their expressions were correlated with clinico-pathological data and survival pattern for the studied GBM patients. Higher levels of both lncRNAs were correlated to worse performance status. Expression of lncRNA565 was increased with large tumor size (≥ 5 cm). Survival analysis showed that both investigated lncRNA were increased with worse PFS and OS. CONCLUSION: Expression of lncRNA565 and lncRNA641 in a liquid biopsy sample can be used as prognostic biomarker for GBM patients.
引用
- Amer RG, Ezz El Arab LR, Abd El Ghany D, et al. Prognostic utility of lncRNAs (LINC00565 and LINC00641) as molecular markers in glioblastoma multiforme (GBM). J Neurooncol. 2022. PMID: 35668225. doi:10.1007/s11060-022-04030-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。